The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

An analysis of pooled data from two large finerenone trials identified key risk factors for hyperkalemia in patients with CKD ...

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that provides messenger RNA medicines ...

San Jose, USA-based biotech Allay Therapeutics today announced the completion of a $57.5 million Series D financing round ...

DataM Intelligence | competitive Intelligence Gene therapies, exon-skipping drugs and next-gen steroids are reshaping Duchenne muscular dys ...

Botanix launches a decentralized Bitcoin sidechain with a 16-node federation, using the Spiderchain protocol for ...

AARP, Con Edison, Delta, Habitat for Humanity, and moreNEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Newsweek, in partnership with Plant-A Insights Group, is proud to announce the results of the America ...

Good morning, and welcome to the day 2 of the Jefferies Healthcare Conference. My name is Dennis Ding, spec pharma analyst here at Jefferies. I have the great pleasure of having the Viatris here, the ...